What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
Saved in:
| Title: | What is a rational antidepressant treatment for major depression in patients with Parkinson's disease? |
|---|---|
| Authors: | Hagikura, Minako (AUTHOR), Iwamoto, Kunihiro (AUTHOR), Aleksic, Branko (AUTHOR), Ozaki, Norio (AUTHOR) |
| Source: | Psychiatry & Clinical Neurosciences. Aug2012, Vol. 66 Issue 5, p463-463. 1p. |
| Subjects: | Case studies, Mental depression, Therapeutics, Parkinson's disease patients, Depressed persons, Drug efficacy, Mirtazapine |
| Abstract: | The article presents a case study of 62-year-old female patient with Parkinson's disease (PD) and mental depression. The patient was treated with milnacipran 75 milligrams (mg) per day without improvement of the depressive symptoms. Her treatment was then changed to mirtazapine 30 mg/day, which resulted to an improvement in her depressive symptoms. The authors suggest the potential of mirtrazapine as treatment of choice for PD patients with depression. |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The article presents a case study of 62-year-old female patient with Parkinson's disease (PD) and mental depression. The patient was treated with milnacipran 75 milligrams (mg) per day without improvement of the depressive symptoms. Her treatment was then changed to mirtazapine 30 mg/day, which resulted to an improvement in her depressive symptoms. The authors suggest the potential of mirtrazapine as treatment of choice for PD patients with depression. |
|---|---|
| ISSN: | 13231316 |
| DOI: | 10.1111/j.1440-1819.2012.02362.x |
